CHINA PHARMACEUTICALS INC Operating Expenses
CHINA PHARMACEUTICALS INC reported Operating Expenses of $1.69 million for the 3-month period ending 2012-06-30, per its 10-Q/A filed 2012-08-27.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2012-08-27
- CHINA PHARMACEUTICALS INC operating expenses for the quarter ending 2012-06-30 was $1.69M, a 70.60% decline year-over-year.
- CHINA PHARMACEUTICALS INC operating expenses for the quarter ending 2012-03-31 was $1.18M, a 20.49% increase year-over-year.
- CHINA PHARMACEUTICALS INC operating expenses for the quarter ending 2011-12-31 was $6.97M.
- CHINA PHARMACEUTICALS INC operating expenses for the quarter ending 2011-09-30 was $2.80M, a 17.31% decline year-over-year.
- CHINA PHARMACEUTICALS INC operating expenses for fiscal 2011 was $16.48M.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2012-06-30 | $1.69M 10-Q/A · filed 2012-08-27 | $2.86M 10-Q/A · filed 2012-08-27 | $9.83M derived: sum of 3 quarters · filed 2012-08-27 | $12.64M derived: sum of 4 quarters · filed 2012-08-27 |
| 2012-03-31 | $1.18M 10-Q · filed 2012-05-21 | $8.15M derived: sum of 2 quarters · filed 2012-05-21 | $10.95M derived: sum of 3 quarters · filed 2012-05-21 | $16.68M derived: sum of 4 quarters · filed 2012-08-27 |
| 2011-12-31 | $6.97M derived: 10-K 12 month − 10-Q 9 month · filed 2012-05-07 | $9.77M derived: sum of 2 quarters · filed 2012-05-07 | $15.51M derived: sum of 3 quarters · filed 2012-08-27 | $16.48M 10-K · filed 2012-05-07 |
| 2011-09-30 | $2.80M 10-Q · filed 2011-11-21 | $8.53M derived: sum of 2 quarters · filed 2012-08-27 | $9.51M 10-Q · filed 2011-11-21 | |
| 2011-06-30 | $5.73M 10-Q/A · filed 2012-08-27 | $6.71M 10-Q/A · filed 2012-08-27 | ||
| 2011-03-31 | $975.37K 10-Q · filed 2012-05-21 | |||
| 2010-09-30 | $3.39M 10-Q · filed 2011-11-21 | $3.11M derived: sum of 2 quarters · filed 2011-11-21 | $6.13M 10-Q · filed 2011-11-21 | |
| 2010-06-30 | -$274.76K 10-Q/A · filed 2011-09-16 | $2.74M 10-Q/A · filed 2011-09-16 |